LU81456A1 - Phenethanolamines et leur utilisation comme potentialisateurs des medicaments destructeurs des cellules cancereuses - Google Patents

Phenethanolamines et leur utilisation comme potentialisateurs des medicaments destructeurs des cellules cancereuses

Info

Publication number
LU81456A1
LU81456A1 LU81456A LU81456A LU81456A1 LU 81456 A1 LU81456 A1 LU 81456A1 LU 81456 A LU81456 A LU 81456A LU 81456 A LU81456 A LU 81456A LU 81456 A1 LU81456 A1 LU 81456A1
Authority
LU
Luxembourg
Prior art keywords
potentializers
phenethanolamines
cancer cell
cell destructive
drugs
Prior art date
Application number
LU81456A
Other languages
English (en)
French (fr)
Inventor
J Mills
K Schmiegel
R Toomey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU81456A1 publication Critical patent/LU81456A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU81456A 1978-07-03 1979-07-02 Phenethanolamines et leur utilisation comme potentialisateurs des medicaments destructeurs des cellules cancereuses LU81456A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92166878A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
LU81456A1 true LU81456A1 (fr) 1979-10-30

Family

ID=25445786

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81456A LU81456A1 (fr) 1978-07-03 1979-07-02 Phenethanolamines et leur utilisation comme potentialisateurs des medicaments destructeurs des cellules cancereuses

Country Status (33)

Country Link
EP (2) EP0047536B1 (ko)
JP (1) JPS559100A (ko)
AR (2) AR222658A1 (ko)
AT (1) AT370408B (ko)
AU (1) AU521744B2 (ko)
BE (1) BE877392A (ko)
BG (3) BG40482A3 (ko)
CA (1) CA1120058A (ko)
CH (1) CH641759A5 (ko)
CS (2) CS208660B2 (ko)
DD (1) DD144763A5 (ko)
DK (1) DK268579A (ko)
EG (1) EG14400A (ko)
ES (2) ES482153A1 (ko)
FI (1) FI67686C (ko)
FR (1) FR2430409A1 (ko)
GB (1) GB2028800B (ko)
GR (1) GR72546B (ko)
HK (1) HK44087A (ko)
HU (1) HU179170B (ko)
IE (1) IE48436B1 (ko)
IL (1) IL57670A (ko)
LU (1) LU81456A1 (ko)
MX (1) MX6160E (ko)
MY (1) MY8500596A (ko)
NZ (1) NZ190859A (ko)
PH (1) PH15650A (ko)
PL (2) PL123990B1 (ko)
PT (1) PT69840A (ko)
RO (2) RO83053B (ko)
SU (2) SU965351A3 (ko)
YU (1) YU154879A (ko)
ZA (1) ZA793295B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0102213A1 (en) * 1982-08-21 1984-03-07 Beecham Group Plc Ethanolamine derivatives, pharmaceutical compositions containing them, and processes for preparing them
PL144053B1 (en) * 1983-01-31 1988-04-30 Lilly Co Eli Method of stimulating growth of domesticated animals,improving effectivness of food utilization ba domesticated animals and improving leanness of domesticated animals and fodder pre-mixture
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
JPS62155213A (ja) * 1985-12-20 1987-07-10 イ−ライ・リリ−・アンド・カンパニ− 腫瘍細胞崩壊剤
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β-拟肾上腺素兴奋剂型饲料添加剂的合成方法
US7547716B2 (en) 2001-06-08 2009-06-16 Institute Of Medicinal Molecular Design, Inc. Sulfonamide derivatives
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6610530A (ko) * 1966-07-27 1968-01-29
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts

Also Published As

Publication number Publication date
AR222658A1 (es) 1981-06-15
SU931102A3 (ru) 1982-05-23
IE791231L (en) 1980-01-03
EP0007206A1 (en) 1980-01-23
FR2430409B1 (ko) 1981-05-29
MY8500596A (en) 1985-12-31
ATA463979A (de) 1982-08-15
NZ190859A (en) 1984-09-28
CS208660B2 (en) 1981-09-15
SU965351A3 (ru) 1982-10-07
ES8101537A1 (es) 1980-12-16
GR72546B (ko) 1983-11-17
IE48436B1 (en) 1985-01-23
FI67686C (fi) 1985-05-10
AR222727A1 (es) 1981-06-15
HU179170B (en) 1982-08-28
RO83053A (ro) 1984-02-21
EG14400A (en) 1983-12-31
GB2028800A (en) 1980-03-12
PL123990B1 (en) 1982-12-31
BG40480A3 (en) 1986-12-15
BG40482A3 (en) 1986-12-15
EP0047536A2 (en) 1982-03-17
FI792080A (fi) 1980-01-04
PH15650A (en) 1983-03-11
DK268579A (da) 1980-01-04
BG40481A3 (en) 1986-12-15
JPS636058B2 (ko) 1988-02-08
RO77731A (ro) 1981-11-24
FR2430409A1 (fr) 1980-02-01
BE877392A (fr) 1980-01-02
GB2028800B (en) 1982-11-03
ES482153A1 (es) 1980-08-16
EP0007206B1 (en) 1983-02-23
EP0047536A3 (en) 1982-03-24
AU4848879A (en) 1980-01-10
AU521744B2 (en) 1982-04-29
YU154879A (en) 1983-04-30
CA1120058A (en) 1982-03-16
EP0047536B1 (en) 1984-06-27
RO83053B (ro) 1984-02-28
DD144763A5 (de) 1980-11-05
MX6160E (es) 1984-11-29
FI67686B (fi) 1985-01-31
AT370408B (de) 1983-03-25
PL119783B1 (en) 1982-01-30
HK44087A (en) 1987-06-12
PL222867A1 (ko) 1981-01-02
PL216810A1 (ko) 1980-07-28
ZA793295B (en) 1981-02-25
ES487847A0 (es) 1980-12-16
IL57670A (en) 1982-11-30
PT69840A (en) 1979-07-01
CS208661B2 (en) 1981-09-15
JPS559100A (en) 1980-01-22
CH641759A5 (fr) 1984-03-15
IL57670A0 (en) 1979-10-31

Similar Documents

Publication Publication Date Title
LU81456A1 (fr) Phenethanolamines et leur utilisation comme potentialisateurs des medicaments destructeurs des cellules cancereuses
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
LU80886A1 (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique
FR2306697A1 (fr) Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
FR2423497B1 (fr) Enzymes immobilisees, leur preparation et leur utilisation
SE7600083L (sv) Litium-jodcell och forfarande for framstellning av denna
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE876040A (fr) Nouvelles piperazines substituees, leur preparation et leur utilisation
BE865165A (fr) Nouveaux 1-amino-indanes et leur utilisation comme medicaments
BE877391A (fr) Phenethanolamines optiquement actives et leur utilisation therapeutique
FR2325635A1 (fr) N-alkyldiphenylamines et leur utilisation comme rodonticides
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE883080A (fr) Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments
DE2967324D1 (en) Pyrrolidine derivatives for use as therapeutically active substances and medicaments containing them
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
DK519080A (da) Elektrode til elektrolyseceller
FR2323388A1 (fr) Nouveaux phenylpiperazinotetrahydronaphtols, leur preparation et leur utilisation therapeutique comme hypotenseurs
BE879558A (fr) Urees et thio-urees pharmacologiquement actives, leur preparation et leur utilisation
IT7950714A0 (it) Ariltrifluoroetanoli procedimento per prepararli e composizioni farmaceutiche che li contengono
BE869560R (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
LU79551A1 (fr) Procede de preparation de nouvelles 3-amino-2-or-propoxy-naphtyridines et leur utilisation
BE863007A (fr) Nouvelles arylenedioxy-bis-dicetones, leur preparation et leur utilisation comme medicaments
BE842348A (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation